Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Modelling the effects of oncogenic change on cerebellar development using human fetal neuroepithelial stem cells

EF 2022-23

Résumé
Medulloblastoma (MB), a cerebellar tumour, is a leading cause of cancer-related death in childhood. About 30% of MBs are driven by sonic hedgehog (SHH) signalling, a developmental signalling pathway causing proliferation of cerebellar granule neuron (CGN) progenitors. Interestingly, SHH-MB is thought to arise in progenitors of the CGN lineage and can block CGN differentiation. Furthermore, although SHH-MB occurs more often in males, pediatric SHH-MB (pSHH-MB) affects males and females equally and often presents with large chromosomal rearrangements. Such patients suffer especially poor outcomes, highlighting a pressing clinical need to understand pSHH-MB. However, a lack of pSHH-MB models presents a critical barrier. Using a model of human CGN development invented by our lab, my goal is to determine at which developmental stage pSHH-MB mutation expressing cells are blocked, thereby laying the groundwork to develop treatments targeting this cell type. I plan to induce either MYCN amplification and TP53 inactivation, or PTCH1 and TRF2 inactivation in male and female CGN lineage progenitors, named neuroepithelial stem (NES) cells. Both sets of mutations are drivers of pSHH-MB and activate SHH-signalling while inducing chromosomal rearrangement. I will then differentiate mutation expressing NES cells towards the CGN lineage and investigate effects on CGN differentiation using transcriptomic studies. Finally, I will test the biological relevance of our system by comparing it to pSHH-MB samples. The proposed study will provide a deeper understanding into the effects of pSHH-MB associated mutations on cerebellar development and in future studies, provide a platform to investigate drug treatments thus having the potential to improve the lives of thousands of patients worldwide.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486553
Name
Charton Connor
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Modelling the effects of oncogenic change on cerebellar development using human fetal neuroepithelial stem cells
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Disease Modelling; Medulloblastoma; Molecular Biology; Sonic-Hedgehog-Medulloblastoma; Stem Cells
Abstract
Medulloblastoma (MB), a cerebellar tumour, is a leading cause of cancer-related death in childhood. About 30% of MBs are driven by sonic hedgehog (SHH) signalling, a developmental signalling pathway causing proliferation of cerebellar granule neuron (CGN) progenitors. Interestingly, SHH-MB is thought to arise in progenitors of the CGN lineage and can block CGN differentiation. Furthermore, although SHH-MB occurs more often in males, pediatric SHH-MB (pSHH-MB) affects males and females equally and often presents with large chromosomal rearrangements. Such patients suffer especially poor outcomes, highlighting a pressing clinical need to understand pSHH-MB. However, a lack of pSHH-MB models presents a critical barrier. Using a model of human CGN development invented by our lab, my goal is to determine at which developmental stage pSHH-MB mutation expressing cells are blocked, thereby laying the groundwork to develop treatments targeting this cell type. I plan to induce either MYCN amplification and TP53 inactivation, or PTCH1 and TRF2 inactivation in male and female CGN lineage progenitors, named neuroepithelial stem (NES) cells. Both sets of mutations are drivers of pSHH-MB and activate SHH-signalling while inducing chromosomal rearrangement. I will then differentiate mutation expressing NES cells towards the CGN lineage and investigate effects on CGN differentiation using transcriptomic studies. Finally, I will test the biological relevance of our system by comparing it to pSHH-MB samples. The proposed study will provide a deeper understanding into the effects of pSHH-MB associated mutations on cerebellar development and in future studies, provide a platform to investigate drug treatments thus having the potential to improve the lives of thousands of patients worldwide.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Charton, Connor
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~